Deferasirox

Deferasirox (marketed as Exjade) is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose. It was approved by the United States Food and Drug Administration (FDA) in November 2005. According to FDA (May 2007), renal failure and cytopenias have been reported in patients receiving deferasirox oral suspension tablets.

Also try this free pdf e-books:

Joseph Jacobs - Europas Fairy Book
Aryeh Kaplan - Sefer Ha Yetzirah
Aleister Crowley - Sepher Sephiroth

Labels: hermes trismegistus  pilgrims progress  iron encaustum  mercurial bird  john biography  basil valentine  alchemical hands  aurora consurgens  lesser invoking ritual  dictionary gnosis esotericism  astologically considered text  critical works crowley